CRH PLC
22 February 2007
N E W S R E L E A S E
February 22nd 2007
CRH ANNOUNCES APPOINTMENT OF CHAIRMAN DESIGNATE
The Board of CRH today appointed Mr. Kieran McGowan as Chairman Designate, to
succeed the present Chairman Mr. Pat Molloy. Mr. Molloy, who has been Chairman
since May 2000 and a Board member since 1997, will retire after the Company's
Annual General Meeting, which is scheduled for 9th May 2007.
Mr. McGowan, who joined the Board of CRH in 1998, was Chief Executive of IDA
Ireland until December 1998. He is a non-executive Director of a number of
companies including Elan Corporation plc, Irish Life & Permanent plc and United
Drug plc. He is also a Director of Enterprise Ireland and Chairman of the
Governing Authority of University College Dublin.
Contact: 353-1-4041000
Liam O'Mahony, Chief Executive
Myles Lee, Finance Director
Eimear O'Flynn, Head of Investor Relations
CRH plc, Belgard Castle , Clondalkin, Dublin 22, Ireland TELEPHONE
+353.1.4041000 FAX +353.1.4041007
E-MAIL mail@crh.com WEBSITE www.crh.com Registered Office, 42 Fitzwilliam Square
, Dublin 2, Ireland
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.